Free Cash Flow

BioXcel Therapeutics, Inc. (BTAI)

$20.59

+1.16 (+5.97%)

Free Cash Flow

Year
A/P
Revenue
Revenue (%)
Operating Cash Flow
Operating Cash Flow (%)
Capital Expenditure
Capital Expenditure (%)
Free Cash Flow

FCF Unlevered from cash flow statement